AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS' COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2013 CONSENSUS STATEMENT - EXECUTIVE SUMMARY

被引：164

作者：

Garber, Alan J. ^{[1
]}

Abrahamson, Martin J. ^{[1
]}

Barzilay, Joshua I. ^{[1
]}

Blonde, Lawrence ^{[1
]}

Bloomgarden, Zachary T. ^{[1
]}

Bush, Michael A. ^{[1
]}

Dagogo-Jack, Samuel ^{[1
]}

Davidson, Michael B. ^{[1
]}

Einhorn, Daniel ^{[1
]}

Garvey, W. Timothy ^{[1
]}

Grunberger, George ^{[1
]}

Handelsman, Yehuda ^{[1
]}

Hirsch, Irl B. ^{[1
]}

Jellinger, Paul S. ^{[1
]}

McGill, Janet B. ^{[1
]}

Mechanick, Jeffrey I. ^{[1
]}

Rosenblit, Paul D. ^{[1
]}

Umpierrez, Guillermo E. ^{[1
]}

Davidson, Michael H. ^{[1
]}

机构：

[1] Amer Assoc Clin Endocrinologists, Jacksonville, FL 32202 USA

来源：

ENDOCRINE PRACTICE | 2013年 / 19卷 / 03期

关键词：

CORONARY-HEART-DISEASE; CONTROLLED-RELEASE PHENTERMINE/TOPIRAMATE; BLOOD-PRESSURE TARGETS; HUMAN NPH INSULIN; ADD-ON THERAPY; BASAL INSULIN; MYOCARDIAL-INFARCTION; PRIMARY-PREVENTION; LDL CHOLESTEROL; HYPERCHOLESTEROLEMIC PATIENTS;

D O I：

10.4158/EP13176.CS

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：536 / 547

页数：12

共 109 条

[1] Clinical results of treating type 2 diabetic patients with sitagliptin, vildagliptin or saxagliptin - diabetes control and potential adverse events [J].

Ahren, Bo .

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) :487-498

[2] Controlled-Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP) [J].

Allison, David B. ;

Gadde, Kishore M. ;

Garvey, William Timothy ;

Peterson, Craig A. ;

Schwiers, Michael L. ;

Najarian, Thomas ;

Tam, Peter Y. ;

Troupin, Barbara ;

Day, Wesley W. .

OBESITY, 2012, 20 (02) :330-342

[3]

[Anonymous], 59 ANN M AM DIAB ASS

[4]

[Anonymous], ACSMS RESOURCE MANUA

[5]

Antihypertensive T., 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI [10.1001/jama.288.23.2981, DOI 10.1001/JAMA.288.23.2981]

[6] Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study [J].

Astrup, Arne ;

Rossner, Stephan ;

Van Gaal, Luc ;

Rissanen, Aila ;

Niskanen, Leo ;

Al Hakim, Mazin ;

Madsen, Jesper ;

Rasmussen, Mads F. ;

Lean, Michael E. J. .

LANCET, 2009, 374 (9701) :1606-1616

[7]

AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917

[8] Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome [J].

Azadbakht, L ;

Mirmiran, P ;

Esmaillzadeh, A ;

Azizi, T ;

Azizi, F .

DIABETES CARE, 2005, 28 (12) :2823-2831

[9] Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].

Baigent, C. ;

Blackwell, L. ;

Emberson, J. ;

Holland, L. E. ;

Reith, C. ;

Bhala, N. ;

Peto, R. ;

Barnes, E. H. ;

Keech, A. ;

Simes, J. ;

Collins, R. .

LANCET, 2010, 376 (9753) :1670-1681

[10] Drug therapy - Metformin [J].

Bailey, CJ ;

Turner, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :574-579

← 1 2 3 4 5 6 7 8 9 10 →